300813.SZ
泰林生物
SZSE · Healthcare · C 制造业 · CN
CNY 20.37
−3.60%Margins
Gross margin
45.7%
EBITDA margin
11.0%
EBIT margin
5.3%
Net margin
5.2%
FCF margin
0.1%
2.2%
Return on equity
1.9%
Return on assets
—
Return on invested capital
0.36x
Asset turnover
CNY 54.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026